The pharmaceutical industry is well-positioned to experience substantial growth in the foreseeable years, thanks to the escalating incidence of chronic diseases, widespread adoption of new technologies, and relentless R&D in the space.
Given the industry tailwinds, it seems wise to invest in fundamentally sound pharma stocks Ipsen S.A. (IPSEY), Supernus Pharmaceuticals, Inc. (SUPN), and Kamada Ltd. (KMDA), currently trading at discounted valuations, for potential gains.
